These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16467225)

  • 21. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
    Harrison-Woolrych M; Ashton J
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varenicline for tobacco dependence.
    Tavares AR
    N Engl J Med; 2009 Feb; 360(7):731. PubMed ID: 19222131
    [No Abstract]   [Full Text] [Related]  

  • 24. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The FDA approves new drug for smoking cessation.
    FDA Consum; 2006; 40(4):29. PubMed ID: 17243286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study].
    Fagerström KO; Gilljam H; Tonstad S
    Lakartidningen; 2011 Nov 2-8; 108(44):2215-7. PubMed ID: 22165180
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
    Graham DJ; By K; McKean S; Mosholder A; Kornegay C; Racoosin JA; Young J; Levenson M; MaCurdy TE; Worrall C; Kelman JA
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1205-12. PubMed ID: 25044169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study.
    Blak BT; Wilson K; Metcalfe M; Maguire A; Hards M
    Curr Med Res Opin; 2010 Apr; 26(4):861-70. PubMed ID: 20144137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On oral medications, especially varenicline].
    Kurioka N
    Nihon Rinsho; 2013 Mar; 71(3):487-92. PubMed ID: 23631241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies linking smoking-cessation drug with suicide risk spark concerns.
    Kuehn BM
    JAMA; 2009 Mar; 301(10):1007-8. PubMed ID: 19278936
    [No Abstract]   [Full Text] [Related]  

  • 34. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varenicline for smoking cessation: definite promise, but no panacea.
    Klesges RC; Johnson KC; Somes G
    JAMA; 2006 Jul; 296(1):94-5. PubMed ID: 16820552
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
    Zeng F; Chen CI; Mastey V; Zou KH; Harnett J; Patel BV
    Am J Manag Care; 2010 Sep; 16(9):667-74. PubMed ID: 20873954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of smoking cessation clinic subjects].
    Shino M; Saito H; Takiguchi S; Kushihashi Y; Suzuki M; Yamada Y; Kadokura Y; Kano M; Suzaki H
    Nihon Jibiinkoka Gakkai Kaiho; 2011 Aug; 114(8):721-5. PubMed ID: 21919308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of varenicline in patients with cardiovascular disease.
    Haber SL; Boomershine V; Raney E
    J Pharm Pract; 2014 Feb; 27(1):65-70. PubMed ID: 24080536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of nicotine dependence with Chantix (varenicline).
    Rankin KV; Jones DL
    Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.
    Liu ME; Tsai SJ; Yang ST
    CNS Spectr; 2009 Jul; 14(7):346. PubMed ID: 19773709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.